Interim Analysis of the Randomized Phase 1b/3 Study Evaluating the Safety and Efficacy of Tazemetostat Plus Lenalidomide and Rituximab in Patients with Relapsed/Refractory Follicular Lymphoma
暂无分享,去创建一个
J. Leonard | J. Pagel | T. Phillips | P. McKay | F. Morschhauser | L. Nastoupil | J. Amengual | Steven I. Park | D. Andorsky | A. Hamlett | C. Batlevi | P. Campbell | Jay Yang | D. Adib | H. O'Connor